Back

Unravelling the progression of hypertrophic cardiomyopathy: computational insights into MYH7 mutations, ionic remodelling, hypertrophy, and targeted therapy development

30 August 2025 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Machine learning for cardiovascular risk assessment: from the heart to the brain In-Silico Medicine and Virtual Physiologic Patient ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Abdallah Hasaballa

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Artificial intelligence and machine learning for predicting mitral regurgitation risk following NeoChord procedure
Doctor F. Serra (Padova, IT)
Abstract Slides Video
Presentation thumbnail
Prospective clinical trials evaluating artificial intelligence in cardiovascular medicine: A scoping review
Ms T. Pequignot (Basel, CH)
Abstract Slides Video
Presentation thumbnail
AI-based identification of acute cellular rejection in digital pathology images of endomyocardial biopsies from heart transplanted patients
Mr E. Buccieri (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
One view to rule them all? Applying artificial intelligence to assess valvular disease and ventricular function using a single apical 4-chamber echocardiographic view
Doctor L. Fisher (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Role of neuropsychiatric treatments and conditions in young SCA patients using IA.
Professor X. Jouven (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Machine learning for cardiovascular risk assessment: from the heart to the brain

The Event

Event poster

ESC Congress 2025

30 August 2025 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of mavacamten on left ventricular myocardial volume, strain and tissue characteristics in patients with hypertrophic cardiomyopathy
thumbnail
Congress Session
Precision medicine in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Contemporary treatment of hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources